posted on 2019-11-11, 16:11authored byMangmang Sang, Renjie Luo, Yidan Bai, Jun Dou, Zhongtao Zhang, Fulei Liu, Feng Feng, Wenyuan Liu
Ferroptosis
is an iron-dependent cell death caused by accumulation
of lipid peroxidation (LPO), which is a new strategy for cancer treatment.
Th current ferroptosis therapy nanodevices have low efficiency and
side effects generally. Hence, we developed a Black Hole Quencher
(BHQ)-based fluorescence “off–on” nanophotosensitizer
complex assembly (CSO-BHQ-IR780-Hex/MIONPs/Sor). CSO-connected BHQ-IR780-Hex
and -loaded magnetic iron oxide nanoparticles (MIONPs) and sorafenib
(Sor) formed a very concise functionalized delivery system. CSO-BHQ-IR780-Hex
disassembled by GSH attack and released IR780-Hex, MIONPs, and sorafenib.
IR780-Hex anchored to the mitochondrial membrane, which would contribute
to amplifying the efficiency of the photosensitizer. When NIR irradiation
was given to CSO-BHQ-IR780-Hex/MIONPs/Sor-treated cells, iron supply
increased, the xCT/GSH/GPX-4 system was triggered, and a lot of LPO
burst. A malondialdehyde test showed that LPO in complex assembly-treated
cells was explosive and increased about 18-fold compared to the control.
The accumulation process of particles was monitored by an IR780-Hex
photosensitizer, which showed an excellent tumor target ability by
magnetic of nanodevice in vivo. Interestingly, the half-life of sorafenib
in a nanodevice was increased about 26-fold compared to the control
group. Importantly, the complex assembly effectively inhibits tumor
growth in the breast tumor mouse model. This work would provide ideas
in designing nanomedicines for the ferroptosis treatment of cancer.